 |
|
|
| |
Futility Testing at Treatment Week 8 in Patients With Hepatitis C Virus (HCV) Genotype 1 Infection Receiving Boceprevir: A Post Hoc Analysis
|
| |
| |
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Ira M. Jacobson,1 Marcelo Silva,2 Savino Bruno,3 Jose-Luis Calleja,4 Bruce Bacon,5 Rafael Esteban,6 Fred Poordad,7 Jean-Pierre Bronowicki,8 Mark S. Sulkowski,9 John M. Vierling,10 Steven Flamm,11 Lynn Colvard,12 Seth Thompson,12 Kenneth Koury,12 Frans A. Helmond,12 Katia Alves,12 Janice Wahl12
1Weill Cornell Medical College, New York, NY, USA; 2Hospital Universitario Austral, Pilar, Argentina; 3Fatebenefratelli e Oftalmico Hospital, Milan, Italy; 4Hospital Universitario Puerta de Hierro, Madrid, Spain; 5Saint Louis University School of Medicine, St Louis, MO, USA; 6Vall d'Hebron University Hospital, Barcelona, Spain; 7The Texas Liver Institute, University of Texas Health
Science Center, San Antonio, TX, USA; 8Centre Hospitalier Universitaire de Nancy, Universite Henri Poincare, Nancy, France; 9Johns Hopkins University School of Medicine, Baltimore, MD, USA; 10Baylor College of Medicine, Houston, Texas, USA; 11Northwestern Feinberg School of Medicine, Chicago, IL, USA; 12Merck & Co., Inc, Whitehouse Station, NJ, USA
|
| |
|
|
|
|
|
